UP COVID CASES
If you test positive for COVID, can you still travel?
With variants KP.2, KP.3, and LB.1 surging, the CDC advises isolation if symptomatic, testing kits, masks, and medications for July 4 travelers. Vicki Sowards suggests Paxlovid for high-risk groups. U.S. citizens no longer need vaccine proof/tests. Adhere to physical distancing, good hygiene, and updated vaccines to curb rising hospitalizations and deaths. Follow CDC guidelines for safe travel.
COVID-19 reaches high level. Hospitalization, emergency visits, deaths go up. What have CDC data revealed?
According to the CDC, Hawaii has registered a substantial rise in the number of people diagnosed with COVID-19, however, Arizona, New Mexico, Florida and Washington have comparatively less number of such people. The numbers for emergency room admissions and deaths have also gone up.
Is the US facing a surge in COVID-19 cases? Symptoms, variants, vaccines and other details
The US is facing a summer surge in COVID-19 cases. The new variants are spreading and this has yet again raised the importance of taking precautions.
Is there yet another COVID outbreak in the UK?
Ahead of the parliamentary elections in the UK, there has been an outbreak of COVID-19 cases, in large numbers. New strains are causing this surge in cases.
FATF session begins today, India review also to be taken up
According to officials, the last mutual evaluation was conducted in 2009 and was delayed due to the Covid-19 pandemic. According to FATF, the international policy making body conducts mutual evaluations of its member countries by evaluating levels of implementation of the FATF recommendations.
Bengaluru dengue cases double. BBMP commissioner infected. Hyderabad warned
As the monsoon progresses, dengue cases in Bengaluru and Hyderabad are increasing. BBMP chief commissioner Tushar Giri Nath has tested positive and is recuperating at home. Dengue cases in Bengaluru have doubled, with 1,036 reported in June. Experts predict a severe dengue season in Telangana, with over 600 cases already recorded.
- Go To Page 1
'Dhoom' actress Rimi Sen reveals how a close friend cheated her of Rs 4 crore. Real-life CID in action
Rimi Sen has been entangled in a legal battle after being defrauded of Rs 4.14 crore by her close friend Ronak Vyas. Two years after filing an FIR, the case is now up for hearing in the Bombay High Court, and a chargesheet will soon be filed. Sen met Vyas at a gym, and he convinced her to invest in his business with promises of high returns. After investing, she realized she had been scammed. Despite initial payments, Vyas began making excuses and disappeared.
Noida extends rehab package offer for projects facing insolvency; Supertech, ATS, Logix Group among defaulters
The Uttar Pradesh government has extended the rehabilitation package for housing project developers facing insolvency proceedings by two weeks. The package offers incentives such as interest waivers and penalties during the pandemic in exchange for withdrawing cases with the NCLT or courts. The package aims to assist developers like Supertech, ATS, and Logix Group who have stalled projects and owe significant dues.
Silver Medal Linings: In sports, business, or elections, it is the runner-up who defines a memorable winner
Evolution has hardwired into us the idea of a winner and, by the principle of complementarity, a loser. Out of breath and hiding away from a sabre-toothed tiger, managing to grab a seat on one of those Polynesian canoes headed to Hawaii (no stops), escaping the yearning jaws of prehistoric crocodiles at a watering hole, it was either ancient cremation rites or a few extra happy years for furthering hominid genes. Not a surprise that our genes learnt to be selfish, to think of a binary of win or lose.
Liquor demand still dull, could pick up soon: United Spirits
"On the demand front, the growth has moderated from two years ago. And at the lower end, we continue to see some pressure. Moderation was there during the wedding season, and so growth is continuing to be slower," the company's managing director and chief executive Hina Nagarajan told analysts during an earnings call.
As COVID cases rise again, what do you need to know about the new FLiRT variants?
FLirt Covid 19 Virus: Scientists are studying the FLiRT variants, subvariants of the Omicron lineage, which may be more contagious and evade immunity better. The FLiRT variants, derived from the JN.1 variant, are demonstrating increased 'fitness' and may become the dominant subvariants in Australia. Booster shots targeting Omicron XBB.1.5 provide significant protection against severe illness.
290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data
India has reported 290 cases of KP.2 and 34 cases of KP.1, both sub-lineages of COVID-19 responsible for a surge in cases in Singapore. However, a Union health ministry source said these are all sub variants of JN1, and there is no associated increase in hospitalization or severe cases. The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has found 34 cases of KP.1 across seven states and UTs, with Maharashtra reporting the highest number at 148.
'Unusual' form of cell death underlies lung damage in Covid patients, finds study
Ferroptosis, a less common cell death type, is linked to severe lung damage in Covid patients, causing inflammation and respiratory complications. Columbia University research highlights ferroptosis as a key factor in Covid-19 lung disease, with implications for treating neurodegenerative conditions like Parkinson's and Alzheimer's. The study was published in the journal Nature Communications.
Creditors' haircuts in bankruptcy cases jump to 73 pc in FY24, resolutions taking longer: Report
Creditors' haircuts in bankruptcy resolutions rose to 73% in FY24 from 64% in FY23. 269 resolution plans were approved by NCLTs, with a decline in new admissions due to Covid-19. The average resolution time also increased, impacting CIRPs and entities. NCLT passed liquidation orders for 446 corporate debtors in FY24.
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
AstraZeneca's COVID-19 prevention therapy, sipavibart, has shown a significant reduction in symptomatic COVID-19 cases among immunocompromised patients, a group comprising about 25% of COVID-19 hospitalizations, ICU admissions, and deaths. The therapy, acquired from RQ Bio in May 2022, is expected to work with regulatory authorities globally to bring sipavibart to these vulnerable patients.
Covaxin side effects: What are the symptoms reported in adverse event cases? Should you worry?
Covaxin side effects: A recent study highlighted adverse events post-Bharat Biotech's Covaxin vaccinations. Led by Sankha Shubhra Chakrabarti, it noted higher risk in female adolescents and those with allergies. Of 1,024 participants, 47.9% adolescents and 42.6% adults reported viral infections. Common AESIs included skin disorders, menstrual abnormalities in females, and serious cases like stroke. Monitoring vaccinated individuals, especially those with prior Covid history, is crucial.
Nearly 100 cases of Covid's new FLiRT variant KP.2 found in Maharashtra: Here are the most affected cities
Maharashtra identifies 91 cases of the Omicron subvariant KP.2, surpassing the JN.1 variant. Pune records the highest number at 51. Dr. Rajesh Karyakarte notes an increase in cases without a rise in hospitalizations. Other cases reported in various cities. FLiRT variants consist of KP.1.1 and KP.2 strains. Japanese researchers identify unique substitutions in the S protein of KP.2 variant.
What is KP.2? Everything about new COVID-19 variant that may increase Corona cases this summer
After JN.1, the latest variety of COVID-19 variants is KP.2. It is an offshoot of the omicron variant. Scientists have said that the KP.2 has three additional mutations in its spike protein compared with JN.1.
Whether sale of products whose licenses were cancelled stopped: SC asks Patanjali
During the bail plea hearing for Sisodia, his lawyer noted that the ED and the CBI continue arrests in the money laundering and corruption case, indicating a protracted trial. The Supreme Court, reserving its order on the contempt notice issued to Ramdev, Balkrishna, and Patanjali Ayurved Ltd in a misleading advertisements case, inquired if the sale of suspended products ceased and urged for an affidavit
Patanjali misleading ads case: SC exempts Ramdev, Balkrishna from personal appearance
The Supreme Court granted Baba Ramdev and Acharya Balkrishna more time to file affidavits in the Patanjali fake advertisements case. The case involves allegations by the Indian Medical Association against Patanjali for disparaging modern medicine and the Covid-19 vaccination drive. The SC also criticized the IMA's president for comments made to the media.
Worrying vaccination gaps come to notice after post-Covid measles spurt forces a data relook
A relook at the survey data was necessitated by instances of repeated measles outbreaks after the COVID-19 pandemic, the report by (by Rema Nagarajan) said.
Uttarakhand accuses Patanjali's Ramdev of misleading public with COVID, other cures
An Indian state has leveled criminal charges against yoga guru Baba Ramdev for promoting his traditional ayurvedic medicine as a COVID-19 cure, despite it being approved only as an "immunity booster." Ramdev faces accusations of misleading the public regarding the efficacy of his medicines, with potential penalties including jail time.
Patanjali Ramdev case: SC tells IMA ‘get your own house in order’, takes notice of other FMCG cos publishing misleading ads
Patanjali Misleading Ads Case: After Patanjali Ayurved apologized for defying Supreme Court orders, the court scrutinized misleading advertisements by various organizations, emphasizing the protection of citizens' interests. Baba Ramdev and Acharya Balkrishna were directed to issue additional apologies within two days. The court also questioned the Indian Medical Association's endorsement of expensive medicines, emphasizing the rule of law.
Patanjali-Ramdev misleading ads case: SC refuses apology again, warns duo to be ready for action in contempt case
The Supreme Court refused to accept Patanjali Ayurved's Baba Ramdev and Acharya Balkrishna's 'unconditional' apology in a contempt case. The court warned them to be prepared for action and criticized the premature media release of their apologies. The case stemmed from allegations of a smear campaign against Covid-19 vaccination and modern medicines.
India reports 272 new Covid infections; active cases dip to 2,990
Covid Cases in India: The number of daily cases had dropped to double-digits till December 5, 2023 but they began to increase after emergence of a new variant and cold weather conditions.
India reports 605 new Covid cases, four deaths
India has reported 605 new COVID-19 cases and four deaths in the last 24 hours, with the country's overall COVID case tally at over 4.5 crore. The death toll reached 5,33,396, with four new deaths reported in the last 24 hours.
Active Covid cases in India rise to 4,394
India has reported 636 new COVID-19 cases and 4,393 active cases, with three new fatalities reported in 24 hours. The pandemic began in early 2020 and has affected over 4.5 crore people and 5.3 lakh deaths in four years. The number of people recovering is over 4.4 crore, with a national recovery rate of 98.81%. 220.67 crore Covid vaccine doses have been administered in India.
Genome sequencing ordered for all Covid cases for detection of JN.1, says Delhi Health Minister
"I have reiterated the directions for genome sequencing of all the positive cases, so that the number of cases of new variants can be confirmed. Yesterday, three variants were confirmed, of which two were of the old Omicron variant and the new one is JN.1 variant. The good thing is that the patient diagnosed with the new variant, who was hospitalised, has been discharged," he told PTI Video.
Mask up, say doctors as Covid-19 cases show a rise
While public health experts expect Covid-19 cases to increase in the winter, they stressed that there is no need to get another vaccine shot as the potential of the latest variant of the coronavirus to cause severe illness is less than the previous variants. In India, the XBB variant continues to be dominant, the data suggest.
Load More
